Senores Pharmaceuticals Ltd

NSE: SENORES · BSE: 544319 · Pharmaceuticals & Biotechnology · 40 announcements

Share price: ₹1,389.60
Market cap: ₹6,400 Cr
Revenue (annual): ₹632.6 Cr
Net profit (annual): ₹115.4 Cr
P/E (TTM): 50.6×Sector 47.3×
Promoter holding: 45.82%+0.00% QoQ
FII holding: 6.62%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 2 Promoter Selling (Off-Market) 1 Promoter Buying (Off-Market) 1 Price Movement Clarification 1 Other Announcement 1 Merger & Restructuring 1 Management Change 1 Debt & Borrowing 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

26 Aug 2026 18:50 IST NSE

Management Change

Senores Pharmaceuticals Management Change

Senores Pharmaceuticals appointed Shilpa Sharma as Company Secretary and Viranchi Arvindbhai Shah as Independent Director. The board also approved a new ESOP scheme.

Read the filing ↗